Lipids and carotid plaque in the Northern Manhattan Study (NOMAS)

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages

  Gardener, Hannah ^a   Morte, David D ^a   Elkind, Mitchell S V ^b   Sacco, Ralph L ^a   Rundek, Tatjana ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CAROTID ARTERY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; STATISTICAL MODEL; STATISTICS; UNITED STATES; URBAN POPULATION;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; RISK FACTORS; STROKE; TRIGLYCERIDES; URBAN POPULATION;

EID: 74549186404     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-55     Document Type: Article

References (49)

1. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apoliproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294:326-333. 10.1001/jama.294.3.326, 16030277.
2. Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L. High-density lipoprotein cholesterol and ischemic stroke in the elderly, the Northern Manhattan Stroke Study. JAMA 2001, 285:2729-2735. 10.1001/jama.285.21.2729, 11386928.
3. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J 2003, 326:1423-1427.
4. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559. 10.1056/NEJMoa061894, 16899775.
5. Davidson MH, Toth PP. High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol 2007, 100:n32-40. 10.1016/j.amjcard.2007.08.011, 18047851.
6. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 2008, 196:489-496. 10.1016/j.atherosclerosis.2007.07.033, 17923134.
7. Subramanian R, Ramaswamy M, Wasan KM. Role of lipid and lipoprotein metabolizing enzymes in the development of atherosclerosis. Indian J Exp Biol 2003, 41:14-25.
8. Morrisett JD. The role of lipoprotein[a] in atherosclerosis. Curr Atheroscler Rep 2000, 2:243-250. 10.1007/s11883-000-0026-z, 11122750.
9. Bersano A, Ballabio E, Lanfranconi S, Mazzucco S, Candelise L, Monaco S. Statins and stroke. Curr Med Chem 2008, 15:2380-2392. 10.2174/092986708785909139, 18855667.
10. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, . Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005, 352:1425-1435. 10.1056/NEJMoa050461, 15755765, Treating to New Targets (TNT) Investigators.
11. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan stroke study. Stroke 2001, 32:1725-1731.
12. Thornberry OTMJ. Coverage and response in random digit dialing national surveys. Proceedings of the Section on Survey Research Methods. 1983, 654-659. Alexandria, VA: American Statistical Association.
13. Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, Marks JS, Trowbridge FL. The behavioural risk factor surveys, II. Design, methods, and estimates from combined state data. Am J Prev Med 1985, 1:9-14.
14. Kargman DE, Sacco RL, Boden-Albala B, Paik MC, Hauser WA, Shea S. Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan stroke study. Neuroepidemiology 1999, 18:174-184. 10.1159/000026209, 10364718.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
16. Paultre F, Tuck CH, Boden-Albala B, Kargman DE, Todd E, Jones J, Paik MC, Sacco RL, Berglund L. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol 2002, 22:141-146. 10.1161/hq0102.101097, 11788474.
17. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol 1997, 17:1822-1829.
18. Gillery P, Arthuis P, Cuperlier C, Circaud R. Rate nephelometric assay of serum lipoprotein(a). Clin Chem 1993, 39:503-508.
19. Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL. Elevated white blood cell count and carotid plaque thickness: the Northern Manhattan Stroke Study. Stroke 2001, 32:842-849.
20. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR, Papapanou PN, Sacco RL. Relationship between periodontal disease, tooth loss and carotid artery plaque: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 2003, 34:2120-2125. 10.1161/01.STR.0000085086.50957.22, 2677013, 12893951.
21. Elkind MS, Cheng J, Boden-Albala B, Rudenk T, Thomas J, Chen H, Rabbani LE, Sacco RL. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002, 33:31-37. 10.1161/hs0102.100531, 2677183, 11779885.
22. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Hank Juo SH, Sacco RL. Carotid intima-media thickness is associated with allelic variants of stromelysin-I, interleukin-6, and hepatic lipase genes: The Northern Manhattan prospective cohort study. Stroke 2002, 33:1420-1423. 10.1161/01.STR.0000015558.63492.B6, 2692936, 11988625.
23. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008, 70:1200-1207. 10.1212/01.wnl.0000303969.63165.34, 18354078.
24. Sacco RL, Gan R, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC. Leisure-time physical activity and ischemic stroke risk: The Northern Manhattan Stroke Study. Stroke 1998, 29:380-387.
25. Lerman-Garber I, Villa AR, Caballero E. Diabetes and cardiovascular disease. Is there a true Hispanic paradox?. Rev Invest Clin 2004, 56:282-296.
26. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:1876-1890. 10.1161/hq1201.100220, 11742859.
27. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
28. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006, 98:1352-1364. 10.1161/01.RES.0000225982.01988.93, 16763172.
29. Barter PJ, Nicholls S, Raye KA, Anatharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004, 95:764-772. 10.1161/01.RES.0000146094.59640.13, 15486323.
30. Panayiotou A, Griffin M, Georgiou N, Bond D, Tyllis T, Tziakouri-Shiakalli C, Fessas C, Nicolaides A. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol 2008, 27:74-80.
31. Junyent M, Zambón D, Gilabert R, Cofán M, Núñez I, Ros E. Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio. Atherosclerosis 2008, 197:740-746. 10.1016/j.atherosclerosis.2007.07.008, 17698072.
32. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 2006, 259:493-519. 10.1111/j.1365-2796.2006.01643.x, 16629855.
33. Olofsson SO, Wiklund O, Borén J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 2007, 3:491-502. 2291326, 17969379.
34. Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, Berenson G. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol 2007, 100:64-68. 10.1016/j.amjcard.2007.01.071, 17599442.
35. Klein JH, Hegele RA, Hackam DG, Koschinsky ML, Huff MW, Spence JD. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol 2008, 28:1851-1856. 10.1161/ATVBAHA.108.169292, 18599799.
36. Paultre F, Tuck CH, Boden-Albala B, Kargman DE, Todd E, Jones J, Paik MC, Sacco RL, Berglund L. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol 2002, 22:141-146. 10.1161/hq0102.101097, 11788474.
37. Marinello E, Setacci C, Giubbolini M, Cinci G, Frosi B, Porcelli B, Terzuoli L. Lipid composition in atheromatous plaque: evaluation of the lipid three-phase percentage. Life Sci 2003, 72:2689-2694. 10.1016/S0024-3205(03)00185-1, 12679186.
38. Kerenyi L, Mihalka L, Csiba L, Bacso H, Bereczki D. Role of hyperlipidemia in atherosclerotic plaque formation in the internal carotid artery. J Clin Ultrasound 2006, 34:283-288. 10.1002/jcu.20233, 16788960.
39. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998, 29:1116-1121.
40. Prati P, Tosetto A, Vanuzzo D, Bader G, Casaroli M, Canciani L, Castellani S, Touboul PJ. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke 2008, 39:2470-2476. 10.1161/STROKEAHA.107.511584, 18617662.
41. Lee EJ, Kim HJ, Bae JM, Kim JC, Han HJ, Park CS, Park NH, Kim MS, Ryu JA. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol 2007, 28:916-919.
42. Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, Sacco RL. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke 2006, 37:2696-2701. 10.1161/01.STR.0000244780.82190.a4, 2654324, 17008627.
43. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, Sharrett AR. Atherosclerosis Risk in Communities Study. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003, 34:623-631. 10.1161/01.STR.0000057812.51734.FF, 12624282.
44. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007, 68:556-562. 10.1212/01.wnl.0000254472.41810.0d, 1805634, 17310025.
45. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004, 63:1868-1875.
46. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004, 117:596-606. 10.1016/j.amjmed.2004.04.022, 15465509.
47. Cheung BM, Lauder IJ, Lau CP, Kumana CR. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 2004, 57:640-651. 10.1111/j.1365-2125.2003.02060.x, 1884492, 15089818.
48. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. High-dose atorvastatin after stroke or transient ischemic attack Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. N Engl J Med 2006, 1(355):549-559.
49. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004, 35:2902-2909. 10.1161/01.STR.0000147965.52712.fa, 15514180.